4.5 Article

The Fra-2 transgenic mouse model of systemic sclerosis

Journal

VASCULAR PHARMACOLOGY
Volume 58, Issue 3, Pages 194-201

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2012.12.001

Keywords

Systemic sclerosis; Animal model; Microangiopathy; Proliferative pulmonary vasculopathy; Fibrosis (Graphical abstract)

Ask authors/readers for more resources

In systemic sclerosis, microvascular injury often precedes the development of fibrosis. Whereas the development of digital ulcers and skin fibrosis causes high morbidity, the affection of internal organs, in particular complications such as interstitial lung disease and pulmonary (arterial) hypertension, account for the high disease-associated mortality of these patients. Vascular animal models of systemic sclerosis are of utmost importance to study pathophysiological aspects, to identify molecular key players, and to perform interventional proof of concept-studies. So far, animal models of systemic sclerosis have mainly reflected the pro-fibrotic features of the human disease. The Fra-2 (Fos-related antigen-2) transgenic mouse model simultaneously displays both pro-fibrotic and vascular characteristics of human systemic sclerosis. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available